Myriad Genetics (MYGN) Competitor Comparison
We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.
Market Capitalization
28 / 58Gross Profits
22 / 52Total Revenue
25 / 57EBITDA
51 / 56Free Cashflow
42 / 56Quick Ratio
44 / 57Earnings per Share
43 / 56Dividend yield
0 / 9Total Cash
36 / 57Performance 3 years
27 / 58Performance 5 years
33 / 58Performance 10 years
37 / 58Linearity 3 years
22 / 58Linearity 5 years
21 / 58Linearity 10 years
13 / 58Total Rank
23 / 58Dividend Rank
22 / 58Valuation Rank
28 / 58Piotroski Rank
50 / 58Muliplier Rank
56 / 58Dividend yield - MYGN ranking 0 / 9
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.